← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

QTRX logoQuanterix Corporation(QTRX)Earnings, Financials & Key Ratios

QTRX•NASDAQ
$3.29
$154M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDevice suppliers, distribution, and services
AboutQuanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.Show more
  • Revenue$139M+2.6%
  • EBITDA-$68M-54.7%
  • Net Income-$107M-178.1%
  • EPS (Diluted)-2.51-151.0%
  • Gross Margin46.77%-21.9%
  • EBITDA Margin-49.31%-50.9%
  • Operating Margin-62.94%-62.0%
  • Net Margin-77.14%-171.2%
  • ROE-34.25%-202.2%
  • ROIC-21.36%-42.8%
  • Debt/Equity0.13+11.2%
Technical→

QTRX Key Insights

Quanterix Corporation (QTRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Trading at only 0.5x book value

✗Weaknesses

  • ✗Profits declining 27.7% over 5 years
  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 7 (bottom 7%)
  • ✗Shares diluted 11.1% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

QTRX Price & Volume

Quanterix Corporation (QTRX) stock price & volume — 10-year historical chart

Loading chart...

QTRX Growth Metrics

Quanterix Corporation (QTRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years27.56%
5 Years9.97%
3 Years9.59%
TTM8.18%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-117.64%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-90.32%

Return on Capital

10 Years-42.19%
5 Years-18.06%
3 Years-16.75%
Last Year-24.68%

QTRX Recent Earnings

Quanterix Corporation (QTRX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Mar 2, 2026
EPS
$0.38
Est $0.27
-40.7%
Revenue
$44M
Est $38M
+14.8%
Q4 2025
Nov 10, 2025
EPS
$0.36
Est $0.23
-56.5%
Revenue
$40M
Est $38M
+5.8%
Q3 2025
Aug 7, 2025
EPS
$0.47
Est $0.41
-14.6%
Revenue
$24M
Est $39M
-36.5%
Q2 2025
May 12, 2025
EPS
$0.53
Est $0.69
+23.2%
Revenue
$30M
Est $28M
+7.1%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 2, 2026
$0.38vs $0.27-40.7%
$44Mvs $38M+14.8%
Q4 2025Nov 10, 2025
$0.36vs $0.23-56.5%
$40Mvs $38M+5.8%
Q3 2025Aug 7, 2025
$0.47vs $0.41-14.6%
$24Mvs $39M-36.5%
Q2 2025May 12, 2025
$0.53vs $0.69+23.2%
$30Mvs $28M+7.1%
Based on last 12 quarters of dataView full earnings history →

QTRX Peer Comparison

Quanterix Corporation (QTRX) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
SEER logoSEERSeer, Inc.Direct Competitor105.44M1.89-1.36-8.13%-486.02%-29.19%0.08
CDNA logoCDNACareDx, IncDirect Competitor1.08B20.94-52.3513.79%-1.98%-2.61%0.06
NTRA logoNTRANatera, Inc.Direct Competitor29.58B215.09-140.5856.75%-14.61%-24.69%0.16
PRAX logoPRAXPraxis Precision Medicines, Inc.Direct Competitor7.61B337.95-25.07-100%-58.74%0.00
BIO logoBIOBio-Rad Laboratories, Inc.Product Competitor6.99B259.029.290.65%6.52%2.4%0.21
MESO logoMESOMesoblast LimitedProduct Competitor2.04B15.81-18.82191.39%-5.94%-17.1%0.21
ABCL logoABCLAbCellera Biologics Inc.Product Competitor1.52B5.04-10.29160.56%-194.89%-15.14%0.14
FLGT logoFLGTFulgent Genetics, Inc.Product Competitor443.83M14.92-7.5713.83%-18.75%-5.42%0.00

Compare QTRX vs Peers

Quanterix Corporation (QTRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SEER

Most directly comparable listed peer for QTRX.

Scale Benchmark

vs TMO

Larger-name benchmark to compare QTRX against a more recognizable public peer.

Peer Set

Compare Top 5

vs SEER, CDNA, NTRA, PRAX

QTRX Income Statement

Quanterix Corporation (QTRX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue22.87M37.63M56.73M86.38M110.56M105.52M121.14M135.44M138.9M144.87M
Revenue Growth %30.08%64.52%50.76%52.25%27.99%-4.55%14.8%11.8%2.56%8.18%
Cost of Goods Sold12.89M19.65M29.9M38.2M45.78M60.16M48.14M54.32M73.94M80.87M
COGS % of Revenue56.34%52.21%52.7%44.22%41.41%57.01%39.74%40.11%53.23%-
Gross Profit
9.99M▲ 0%
17.98M▲ 80.1%
26.84M▲ 49.2%
48.18M▲ 79.5%
64.77M▲ 34.4%
45.36M▼ 30.0%
73M▲ 60.9%
81.12M▲ 11.1%
64.96M▼ 19.9%
63.93M▲ 0%
Gross Margin %43.66%47.79%47.3%55.78%58.59%42.99%60.26%59.89%46.77%44.13%
Gross Profit Growth %28.9%80.07%49.22%79.54%34.43%-29.97%60.91%11.13%-19.92%-
Operating Expenses35.99M49.07M68.44M79.77M121.29M149.63M118.99M133.74M152.37M183.75M
OpEx % of Revenue157.35%130.39%120.63%92.35%109.71%141.8%98.22%98.74%109.7%-
Selling, General & Admin19.69M33.78M52.25M59.59M92.91M91.85M92.82M104.64M138.01M135.9M
SG&A % of Revenue86.07%89.75%92.09%68.99%84.04%87.04%76.63%77.26%99.36%-
Research & Development16.3M15.29M16.19M20.17M28.38M26.81M26.06M31.08M35.92M33.21M
R&D % of Revenue71.28%40.64%28.54%23.36%25.67%25.41%21.52%22.95%25.86%-
Other Operating Expenses-62K-7K00030.97M99K-1.99M-21.56M1.9M
Operating Income
-26M▲ 0%
-31.55M▼ 21.3%
-41.6M▼ 31.9%
-31.58M▲ 24.1%
-56.52M▼ 79.0%
-104.26M▼ 84.5%
-45.99M▲ 55.9%
-52.62M▼ 14.4%
-87.42M▼ 66.1%
-139.66M▲ 0%
Operating Margin %-113.69%-83.84%-73.32%-36.57%-51.12%-98.81%-37.97%-38.85%-62.94%-96.4%
Operating Income Growth %-19.78%-21.32%-31.85%24.08%-78.95%-84.47%55.89%-14.41%-66.14%-
EBITDA-25.52M-30.2M-38.59M-27.27M-51.64M-98.86M-37.7M-44.26M-68.49M-124.98M
EBITDA Margin %-111.58%-80.25%-68.02%-31.57%-46.71%-93.68%-31.12%-32.68%-49.31%-86.27%
EBITDA Growth %-20.01%-18.32%-27.79%29.33%-89.36%-91.43%61.86%-17.4%-54.74%-128.04%
D&A (Non-Cash Add-back)482K1.35M3.01M4.31M4.88M5.41M8.29M8.36M18.93M14.68M
EBIT-26.07M-31.55M-41.6M-31.58M-56.52M-73.3M-44.66M-52.62M-87.42M-89.3M
Net Interest Income-951K46K627K-273K-403K5.13M15.84M14.65M8.57M5.3M
Interest Income1K46K627K005.13M15.84M14.65M8.57M6.19M
Interest Expense952K00273K403K00000
Other Income/Expense-1.01M39K617K-322K937K4.85M18.36M14.52M-24.86M9.44M
Pretax Income
-27.02M▲ 0%
-31.05M▼ 14.9%
-40.98M▼ 32.0%
-31.91M▲ 22.1%
-55.58M▼ 74.2%
-99.41M▼ 78.8%
-27.64M▲ 72.2%
-38.1M▼ 37.9%
-112.27M▼ 194.7%
-106.4M▲ 0%
Pretax Margin %-118.12%-82.5%-72.24%-36.94%-50.28%-94.21%-22.81%-28.13%-80.83%-73.45%
Income Tax025K-187K-376K-36K164K719K434K-5.12M-2.21M
Effective Tax Rate %0%-0.08%0.46%1.18%0.06%-0.16%-2.6%-1.14%4.56%2.08%
Net Income
-27.02M▲ 0%
-31.05M▼ 14.9%
-40.8M▼ 31.4%
-31.53M▲ 22.7%
-55.55M▼ 76.2%
-99.57M▼ 79.3%
-28.35M▲ 71.5%
-38.53M▼ 35.9%
-107.15M▼ 178.1%
-104.19M▲ 0%
Net Margin %-118.12%-82.5%-71.91%-36.5%-50.24%-94.36%-23.41%-28.45%-77.14%-71.92%
Net Income Growth %-16.6%-14.9%-31.41%22.71%-76.18%-79.26%71.52%-35.89%-178.09%-117.64%
Net Income (Continuing)-27.02M-31.54M-40.8M-31.53M-55.55M-99.57M-28.35M-38.53M-107.15M-104.19M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-1.24▲ 0%
-1.39▼ 12.1%
-1.63▼ 17.3%
-1.07▲ 34.4%
-1.60▼ 49.5%
-2.61▼ 63.1%
-0.86▲ 67.0%
-1.00▼ 16.3%
-2.51▼ 151.0%
-2.22▲ 0%
EPS Growth %13.29%-12.1%-17.27%34.36%-49.53%-63.13%67.05%-16.28%-151%-90.32%
EPS (Basic)-1.24-1.41-1.63-1.07-1.60-2.61-0.86-1.00-2.51-
Diluted Shares Outstanding21.71M22.37M25.09M29.59M36M36.99M37.59M38.37M42.64M46.98M
Basic Shares Outstanding21.71M21.99M25.09M29.59M36M36.99M37.59M38.37M42.64M46.98M
Dividend Payout Ratio----------

QTRX Balance Sheet

Quanterix Corporation (QTRX) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets89.25M60.51M132.66M219.6M448.95M381.52M382.1M363.59M212.26M185.72M
Cash & Short-Term Investments79.68M45.43M109.16M181.58M396.46M338.74M321.32M289.12M118.23M99.27M
Cash Only79.68M45.43M109.16M181.58M396.46M338.74M174.42M56.71M29.84M36.18M
Short-Term Investments000000146.9M232.41M88.39M63.08M
Accounts Receivable5.6M6.79M10.91M17.18M23.79M19.02M25.41M32.14M29.97M26.78M
Days Sales Outstanding89.3465.8870.1672.6178.5365.7876.5786.6278.7671.38
Inventory3.57M5.96M10.46M14.86M22.19M16.96M26.12M32.77M54.76M50.96M
Days Inventory Outstanding101.14110.76127.73141.97176.9102.92198.05220.24270.34215.32
Other Current Assets400K2.33M006.51M6.8M9.23M9.56M9.29M8.72M
Total Non-Current Assets2.53M7.12M37.29M51.44M57.56M52.06M46.47M42.94M206.51M180.95M
Property, Plant & Equipment1.87M2.92M12.05M25.91M29.45M41.03M36.18M33.49M40.34M37.23M
Fixed Asset Turnover12.21x12.87x4.71x3.33x3.75x2.57x3.35x4.04x3.44x3.77x
Goodwill01.31M9.35M10.46M9.63M00026.38M26.71M
Intangible Assets02.35M14.31M13.72M10.53M7.52M6.03M4.03M131.79M109.16M
Long-Term Investments653K1M1.03M02.58M2.6M0003.44M
Other Non-Current Assets-1K536K-1.67M1.36M378K-6.86M4.26M5.42M8.01M25.5M
Total Assets
91.78M▲ 0%
67.63M▼ 26.3%
169.95M▲ 151.3%
271.05M▲ 59.5%
506.51M▲ 86.9%
433.58M▼ 14.4%
428.57M▼ 1.2%
406.53M▼ 5.1%
418.77M▲ 3.0%
366.67M▲ 0%
Asset Turnover0.25x0.56x0.33x0.32x0.22x0.24x0.28x0.33x0.33x0.36x
Asset Growth %147.27%-26.31%151.3%59.48%86.87%-14.4%-1.16%-5.14%3.01%-5.14%
Total Current Liabilities19.71M17.66M19.83M39.8M36.98M31.35M38.98M42.01M74.76M49.91M
Accounts Payable3.55M5.11M5.78M6.8M9.21M3.84M5.05M6.95M13.57M8.66M
Days Payables Outstanding100.694.9370.5364.9773.4223.2738.2746.7266.9847.37
Short-Term Debt5.04M075K7.67M1.43M2.69M0007.93M
Deferred Revenue (Current)4.94M5.44M4.7M5.42M6.36M8.64M9.47M8.83M20.73M66.26M
Other Current Liabilities3.56M3.13M2.71M13.83M6.73M5.15M14.17M12.62M31.43M26.78M
Current Ratio4.53x3.43x6.69x5.52x12.14x12.17x9.80x8.66x2.84x2.84x
Quick Ratio4.35x3.09x6.16x5.14x11.54x11.63x9.13x7.88x2.11x2.11x
Cash Conversion Cycle89.8881.7127.37149.61182.02145.43236.35260.14282.12239.32
Total Non-Current Liabilities6.2M8.41M21.46M25.12M28.59M44.3M39.63M34.49M80.21M34.63M
Long-Term Debt4.35M7.62M7.59M00000027.4M
Capital Lease Obligations00021.89M20.46M41.42M37.22M32.62M29.32M91.41M
Deferred Tax Liabilities002.83M2.65M7.02M9.24M1.18M800K32.38M32.38M
Other Non-Current Liabilities144K278K10.58M00-7.77M0012.68M36.62M
Total Liabilities25.91M26.07M41.29M64.92M65.56M75.65M78.61M76.5M123.04M84.53M
Total Debt9.38M7.62M7.66M30.8M21.89M44.1M41.46M37.37M37.24M35.34M
Net Debt-70.3M-37.81M-101.49M-150.79M-374.57M-294.64M-132.96M-19.34M7.4M-846K
Debt / Equity0.14x0.18x0.06x0.15x0.05x0.12x0.12x0.11x0.13x0.13x
Debt / EBITDA----------0.28x
Net Debt / EBITDA---------0.01x
Interest Coverage-27.38x---115.69x-140.25x-----
Total Equity
65.87M▲ 0%
41.56M▼ 36.9%
128.66M▲ 209.6%
206.13M▲ 60.2%
440.95M▲ 113.9%
357.93M▼ 18.8%
349.96M▼ 2.2%
330.04M▼ 5.7%
295.73M▼ 10.4%
282.14M▲ 0%
Equity Growth %388.77%-36.91%209.6%60.21%113.92%-18.83%-2.23%-5.69%-10.4%-41.56%
Book Value per Share3.031.865.136.9712.259.689.318.606.946.01
Total Shareholders' Equity65.87M41.56M128.66M206.13M440.95M357.93M349.96M330.04M295.73M282.14M
Common Stock22K22K28K32K37K37K38K39K47K47K
Retained Earnings-144.35M-175.89M-216.24M-247.77M-305.46M-403.2M-431.55M-470.08M-577.23M-594.77M
Treasury Stock0000000000
Accumulated OCI-2.42M-3.02M-153K2.43M441K-2.54M-1.67M-3.08M-723K-1.01M
Minority Interest0000000000

QTRX Cash Flow Statement

Quanterix Corporation (QTRX) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-22.11M-28.72M-26.19M-23.36M-47.91M-48.27M-18.9M-35.16M-77.24M-77.24M
Operating CF Margin %-96.64%-76.32%-46.16%-27.05%-43.33%-45.75%-15.6%-25.96%-55.61%-
Operating CF Growth %-24.6%-29.92%8.82%10.78%-105.04%-0.76%60.84%-86.03%-119.65%-944.59%
Net Income-27.02M-31.54M-40.8M-31.53M-57.69M-96.7M-32.33M-38.53M-107.15M-104.19M
Depreciation & Amortization482K1.35M3.01M4.31M4.85M5.35M8.38M8.36M18.93M22.58M
Stock-Based Compensation2.17M4.88M6.39M10.1M15.97M15.44M16.76M19.99M20.72M14.31M
Deferred Taxes90K-14K140K416K801K-226K00-5.87M-5.87M
Other Non-Cash Items238K170K700K808K340K25.79M92K-6.19M-1.51M-6.58M
Working Capital Changes1.94M-3.58M4.37M-7.47M-12.19M2.07M-11.8M-18.79M-2.35M-1.72M
Change in Receivables-1.68M-983K-3.37M-6.24M-6.85M5.16M-6.7M-7.7M10.61M9M
Change in Inventory-2.04M-1.6M-3.45M-5.12M-8.09M5.39M-5.36M-6.68M4.03M5.17M
Change in Payables1M1.32M621K649K2.41M-5.36M1.19M723K-528K-5.77M
Cash from Investing-1.13M-5.45M-25.38M-626K-6.34M-11.21M-148.4M-82.27M50.23M42.73M
Capital Expenditures-1.13M-1.52M-10.85M-3.93M-13.62M-11.73M-3.79M-3.37M-2.61M-1.44M
CapEx % of Revenue4.95%4.03%19.12%4.55%12.32%11.11%3.13%2.49%1.88%-
Acquisitions0-3.8M-14.53M00000-93.23M-84.23M
Investments----------
Other Investing015K03.3M7.28M520K0000
Cash from Financing73.25M-78K116.2M96.24M270.8M2.31M2.69M456K-708K-1.57M
Debt Issued (Net)-980K-1.93M-50K-75K-7.74M00000
Equity Issued (Net)74M-20K112.55M91.4M269.72M2.31M2.89M3.07M738K-359K
Dividends Paid0000000000
Share Repurchases0-20K0000000-429K
Other Financing231K1.87M3.7M4.91M8.81M0-198K-2.61M-1.45M-1.21M
Net Change in Cash
50.01M▲ 0%
-34.25M▼ 168.5%
64.75M▲ 289.0%
72.4M▲ 11.8%
216.46M▲ 199.0%
-57.7M▼ 126.7%
-164.31M▼ 184.7%
-117.71M▲ 28.4%
-26.14M▲ 77.8%
-40.32M▲ 0%
Free Cash Flow
-23.24M▲ 0%
-30.24M▼ 30.1%
-37.03M▼ 22.5%
-27.3M▲ 26.3%
-61.52M▼ 125.4%
-60M▲ 2.5%
-22.69M▲ 62.2%
-38.53M▼ 69.8%
-79.85M▼ 107.2%
-82.9M▲ 0%
FCF Margin %-101.59%-80.35%-65.28%-31.6%-55.65%-56.86%-18.73%-28.45%-57.49%-57.22%
FCF Growth %-27.21%-30.13%-22.47%26.3%-125.4%2.48%62.18%-69.82%-107.23%-151.16%
FCF per Share-1.07-1.35-1.48-0.92-1.71-1.62-0.60-1.00-1.87-1.87
FCF Conversion (FCF/Net Income)0.82x0.93x0.64x0.74x0.86x0.48x0.67x0.91x0.72x0.80x
Interest Paid0000000000
Taxes Paid00000684K808K875K0385K

QTRX Key Ratios

Quanterix Corporation (QTRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)-68.11%-57.8%-47.94%-18.84%-17.17%-24.93%-8.01%-11.33%-34.25%-35.17%
Return on Invested Capital (ROIC)--631%-201.84%-57.42%-69.65%-120.61%-24.61%-14.96%-21.36%-21.36%
Gross Margin43.66%47.79%47.3%55.78%58.59%42.99%60.26%59.89%46.77%44.13%
Net Margin-118.12%-82.5%-71.91%-36.5%-50.24%-94.36%-23.41%-28.45%-77.14%-71.92%
Debt / Equity0.14x0.18x0.06x0.15x0.05x0.12x0.12x0.11x0.13x0.13x
Interest Coverage-27.38x---115.69x-140.25x-----
FCF Conversion0.82x0.93x0.64x0.74x0.86x0.48x0.67x0.91x0.72x0.80x
Revenue Growth30.08%64.52%50.76%52.25%27.99%-4.55%14.8%11.8%2.56%8.18%

QTRX SEC Filings & Documents

Quanterix Corporation (QTRX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Jan 8, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 17, 2025·SEC

10-Q Quarterly Reports

4
FY 2026

May 6, 2026·SEC

FY 2025

Nov 10, 2025·SEC

FY 2025

Aug 7, 2025·SEC

QTRX Frequently Asked Questions

Quanterix Corporation (QTRX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Quanterix Corporation (QTRX) reported $144.9M in revenue for fiscal year 2025. This represents a 1089% increase from $12.2M in 2015.

Quanterix Corporation (QTRX) grew revenue by 2.6% over the past year. Growth has been modest.

Quanterix Corporation (QTRX) reported a net loss of $104.2M for fiscal year 2025.

Dividend & Returns

Quanterix Corporation (QTRX) has a return on equity (ROE) of -34.2%. Negative ROE indicates the company is unprofitable.

Quanterix Corporation (QTRX) had negative free cash flow of $82.9M in fiscal year 2025, likely due to heavy capital investments.

Explore More QTRX

Quanterix Corporation (QTRX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.